The administration said it intends to use poison control records and other databases to better identify CBD products associated with adverse events. A new opt-in registry for CBD consumers is also in the works.
As progressive reform slowly arrives to cannabis and psychedelics possession, attention will inevitably be given to how the substances can interact. So, what do we already know?
Following a two-year longitudinal study, the researchers concluded that cannabis withdrawal should be considered on a scale of severity, rather than as distinct subtypes of withdrawal syndromes.
The adult-use cannabis extracts and pre-rolls initially failed state testing requirements and are considered unsafe for consumers.
The clinical trial found that Epidiolex can reduce the number of seizures in patients with tuberous sclerosis complex (TSC) by around 50 percent, compared to baseline levels.
Albert Garcia-Romeu, an assistant professor at the Center for Psychedelic and Consciousness Research at Johns Hopkins University, walks Analytical Cannabis through the past, present, and future of psychedelic research.
Female rats, who had been trained to inhale cannabis vapor daily, developed a blunted psychological response to stress, according to new research out of Washington State University.
It's already Europe’s largest legitimate medical industry. So, where does the Germany medical cannabis market go from here?
QNTM Labs has announced a collaboration with the University of Southern Denmark to create the Global Cannabinoid Research Center in Odense, Denmark.